A preparation method of Pro.GHK-Cu blue copper peptide with barrier repair and anti-aging effects
By expressing the peptide alpha GHK28 in E. coli, performing trypsin cleavage and copper chloride chelation, the problem of high cost and low yield of blue copper peptide production is solved, and the low-cost mass production of high-purity blue copper peptide is achieved. .
Patent Information
- Application Number
- CN202410664944.2
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2024-05-27
- Publication Date
- 2024-11-12
- Estimated Expiration
- 2044-05-27
AI Technical Summary
The existing blue copper peptide production methods have high cost, unfriendly environment, low yield and complex purification steps, which limit their large-scale application.
The polypeptide alpha GHK28 was expressed in E. coli by biosynthesis, and high-purity blue copper peptide was prepared by trypsin cleavage and copper chloride chelation, and the reaction conditions were optimized to improve expression and purity.
It has achieved low-cost and large-scale production of blue copper peptides, which has improved the expression amount and purity, reduced the process time and cost, and is suitable for industrial production.
Smart Images

Figure CN118580375B_ABST
Abstract
Description
Technical Field
[0001] The invention relates to a method for preparing Pro.GHK-Cu blue copper peptide with barrier repair and anti-aging effects, belonging to the technical field of protein expression. Background Art
[0002] Blue copper peptide (GHK-Cu) is the complex product of Gly-His-Lys (GHK) tripeptide-1 and copper ions. It is named blue copper peptide because its aqueous solution is blue. It is a small molecule copper peptide complex naturally present in human plasma, urine, saliva, and cerebrospinal fluid. GHK is a tripeptide first isolated from human plasma by Pickart et al. in 1973. It is described as a growth factor for a variety of differentiated cells and a regulator of the extracellular matrix. Later, it was discovered that GHK has a high affinity with divalent copper and can spontaneously bind to it to form a complex GHK-Cu.
[0003] Tripeptide-1 can exchange copper ions with albumin in serum, and at the same time, it can deliver copper ions to tissue cells as a transporter of copper ions. This complex formed by GHK and copper ions is the well-known blue copper peptide. Scientists have conducted systematic research on blue copper peptides, laying the scientific foundation for blue copper peptides as active ingredients for effective skin care. Today, blue copper peptides have become a popular skin care ingredient with multiple functions such as wrinkle removal, soothing, repairing, and anti-oxidation; products containing blue copper peptides are also very helpful in inhibiting excessive sebum secretion, brightening and even skin tone.
[0004] The preparation of blue copper peptides usually adopts biosynthesis or chemical synthesis to obtain tripeptide-1, and then it is complexed with a solution containing copper ions to obtain blue copper peptides. At present, most blue copper peptides on the market are produced by chemical synthesis. The production cost of small-scale short peptides is extremely high, and it also has the disadvantages of many reaction by-products, unfriendly environment, low yield, high reaction substrate and reagent prices. The biosynthesis method is mainly used to produce proteins with larger molecular weight. Relatively speaking, the expression levels of small molecule proteins or short peptides are low, which is not suitable for large-scale production and fermentation in factories. In addition, the subsequent purification steps of the biosynthesis method are relatively complicated and cumbersome, and the recovery rate is not high. In summary, no matter what method is used to produce blue copper peptides, there is a high cost, which limits its application. Summary of the invention
[0005] The purpose of the present invention is to provide a method for preparing Pro.GHK-Cu blue copper peptide with barrier repair and anti-aging effects.
[0006] The technical solution adopted by the present invention is:
[0007] A polypeptide alpha GHK28, whose amino acid sequence is shown as SEQ ID No.2.
[0008] The nucleotide sequence of the gene encoding the aforementioned polypeptide alpha GHK28 is shown in SEQ ID No.1.
[0009] A plasmid expression vector, which expresses the aforementioned polypeptide alpha GHK28.
[0010] Preferably, the plasmid expression vector is pET30a-alpha GHK28.
[0011] A host bacterium expressing the aforementioned polypeptide alpha GHK28.
[0012] Preferably, the host bacteria is Escherichia coli.
[0013] A method for preparing tripeptide-1, comprising the steps of:
[0014] (1) constructing the aforementioned plasmid expression vector and transforming it into a host bacterium;
[0015] (2) Cultivating the expression host bacteria and inducing the expression of the recombinant protein;
[0016] (3) purifying the expression product to obtain polypeptide alpha GHK28;
[0017] (4) The polypeptide alpha GHK28 was digested with trypsin and then separated and purified to obtain tripeptide-1.
[0018] Preferably, in step (4), the enzyme cleavage temperature is 18-30°C, the enzyme cleavage time is 4-8h, and the reaction buffer is dd H 2 O.
[0019] A method for preparing Pro.GHK-Cu blue copper peptide with barrier repair and anti-aging effects, the steps comprising:
[0020] (1) constructing the aforementioned plasmid expression vector and transforming it into a host bacterium;
[0021] (2) Cultivating the expression host bacteria and inducing the expression of the recombinant protein;
[0022] (3) purifying the expression product to obtain polypeptide alpha GHK28;
[0023] (4) digesting the polypeptide alpha GHK28 with trypsin, separating and purifying to obtain tripeptide-1;
[0024] (5) Tripeptide-1 chelates with copper ions to obtain blue copper peptide.
[0025] Preferably, in step (4), the enzyme digestion temperature is 18-30° C., the enzyme digestion time is 4-8 h, and the reaction buffer is B1 buffer.
[0026] Preferably, in step (5), cupric chloride solution is used as the chelating agent.
[0027] Beneficial effects of the present invention:
[0028] The present invention designs an amino acid sequence at the N-terminus of tripeptide-1, which can form an amphipathic alpha helix, thereby forming an aggregate after expression - orderly self-assembly into a precipitate, which, on the one hand, protects the tripeptide-1 from being easily degraded and greatly reduces the toxic damage of small molecule polypeptides to the expression host; on the other hand, the expressed polypeptide can be precipitated and can be separated and purified efficiently and quickly, greatly saving the time and cost of downstream processes; at the same time, it can also increase the expression amount of blue copper peptide.
[0029] The present invention tests different enzyme cleavage reaction media and finds that the use of B1 buffer can effectively reduce the impurity proteins in the supernatant; and blue copper peptide crystals with a purity of not less than 98% can be obtained according to the optimized experimental steps.
[0030] The blue copper peptide of the present invention is selected for biosynthesis and expressed in Escherichia coli, which has a short expression cycle and low cost and is suitable for large-scale production. 600 is about 4, the yield of tripeptide-1 is about 220 mg / L, and the OD 600 If increased to 150-200, the yield can reach 10-15g / L. BRIEF DESCRIPTION OF THE DRAWINGS
[0031] Figure 1 The SDS-PAGE gel image of the expression of alpha GHK28 of the present invention, lane 1 is the supernatant after alpha GHK28 is crushed, lane 2 is the precipitate after alpha GHK28 is crushed, and lane 3 is the protein Maker.
[0032] Figure 2 The SDS-PAGE gel image of the alpha GHK28 digestion of the present invention, from left to right, lane 1 is the supernatant after alpha GHK28 is broken, lane 2 is the precipitate after alpha GHK28 is broken, lane 3 is the protein Maker, lanes 4-6 are the digestion conditions using B1 buffer as the reaction medium, lanes 7-9 are the digestion conditions using 50 mM Tris-HCl, pH 9.0 as the reaction medium; lanes 10-12 are the digestion conditions using H 2 O is the enzyme cleavage condition of the reaction medium, and the 13th lane is the protein Maker (wherein the labels 1: sample solution after reaction; 2: supernatant of sample solution after reaction; 3: precipitate of sample solution after reaction).
[0033] Figure 3 HPLC peak diagram of GHK-Cu of the present invention. DETAILED DESCRIPTION
[0034] The present invention is further illustrated by examples below, but is not intended to be limiting of the present invention. The specific materials used in the embodiments of the present invention and their sources are provided below. However, it should be understood that these are merely exemplary and are not intended to limit the present invention, and materials identical or similar to the types, models, qualities, properties or functions of the following reagents and instruments can be used to implement the present invention. The experimental methods used in the following examples are conventional methods unless otherwise specified. The materials, reagents, etc. used in the following examples, unless otherwise specified, can all be obtained from commercial sources.
[0035] Example 1: Construction of Tripeptide-1
[0036] (1) Gene design and primer synthesis
[0037] In the present invention, an amphipathic alpha helix sequence is formed at the N-terminus of the tandem tripeptide-1 sequence, as shown in Seq ID NO.2. According to the codon preference of Escherichia coli, the optimized nucleotide sequence is shown in Seq ID NO.1.
[0038] The above sequence was entrusted to Beijing Liuhe BGI Gene Technology Co., Ltd. for codon optimization and gene fragment synthesis, and the synthesized gene fragment was inserted into the pET28a expression vector to obtain the corresponding recombinant plasmid.
[0039] The recombinant plasmid was used as a template for PCR amplification, and the amplified target gene fragment was connected with the pET30a expression vector backbone through Gibson-plasmind connection to obtain the corresponding plasmid;
[0040] Primer design:
[0041] Primer name Sequence Listing No. Primer sequences Skeleton-F Seq ID NO.3 GTTATGAACCACAACGCCTTC Skeleton-R Seq ID NO.4 CACCACCACCACCACTTGCTG Alpha GHK28-F Seq ID NO.5 TTGCTGCTGCTTCTTTTGCTGCTGC Alpha GHK28-R Seq ID NO.6 GCTGCTGCTTCTTTTGCTGCTGCTTC
[0042] The ligation product was transformed into the host bacteria E. coli DH5α by the heat shock method, coated with LB culture resistance plates, and incubated at 37°C overnight. Positive clones were randomly picked into LB liquid culture medium and cultured at 37°C, 220rpm overnight. Part of the bacterial solution was sent to Sangon Biotechnology Co., Ltd. for sequencing. The DNA sequencing results were then compared with the plasmid map. The bacterial solution with correct sequencing was selected and the plasmid was extracted using a plasmid rapid extraction kit to obtain the recombinant plasmid pET30a-Alpha GHK28.
[0043] (3) Construction of engineered bacteria
[0044] The above recombinant expression plasmid was transferred into Escherichia coli competent cells BL21 (DE3), and positive Escherichia coli genetically engineered bacteria were screened. The specific process was as follows: ① 1 μL of the plasmid was added to 100 μL of Escherichia coli competent cells BL21 (DE3), and the mixture was placed on ice for 30 min; ② the mixture was heat-shocked in a 42°C water bath for 90 s, and then quickly placed on ice for 2 min; ③ 500 μL of LB liquid medium without resistance (10 g / L peptone, 5 g / L PBS) was added to the mixture. L yeast extract, 10g / L sodium chloride), 37°C, 220rpm conditions for 1h; ④ Take 200μL of the bacterial solution and evenly spread it on an LB solid culture medium plate containing kanamycin (10g / L peptone, 5g / L yeast extract, 10g / L sodium chloride, 15g / L agar, 100μg / mL kanamycin); ⑤ Invert the plate and culture it in a 37°C constant temperature box for about 16h, until clearly visible colonies grow, the corresponding engineered bacteria are obtained, and one-step induced expression can be performed.
[0045] Example 2: Inducible expression of blue copper peptide
[0046] The selected genetically engineered single colony of Escherichia coli was selected from the above LB plate, placed in LB liquid culture medium containing kanamycin antibiotics, and cultured at 37°C and 220rpm for 12-16h; transferred to LB liquid culture medium for fermentation at 2% inoculation volume, cultured at 37°C and 220rpm, and OD 600 When the value reached 0.4-0.6, 0.4 mM IPTG was added to induce expression at 30°C for 6 h.
[0047] Resuspend the cells in lysis buffer B1 (20mM Tris-HCl, 1mM EDTA, 500mM NaCl, pH8.5), add 100X protease inhibitor PMSF, resuspend the cells at a concentration of 20OD / mL, and disrupt the cells. Centrifuge at 4°C, 15000g for 20min to separate the supernatant and precipitate. Resuspend and wash the precipitate once with buffer (same as above), and keep a sample for SDS-PAGE identification. After washing, centrifuge at 4°C, 15000g for 20min to separate the supernatant and precipitate. Discard the supernatant and wash with ddH 2 O Wash the surface of the precipitate once (do not resuspend). Take 80 μL of supernatant and precipitate, add 20 μL of 5× protein loading buffer, mix, heat in a boiling water bath for 10 minutes, and perform SDS-PAGE. The results are as follows: Figure 1 shown.
[0048] Example 3: Enzyme Digestion
[0049] (1) Use trypsin to cleave the recombinant protein. 2 O was used as the reaction system, the inclusion body protein dissolved above was taken, trypsin was added at a mass ratio of fusion protein: trypsin = 100:1, and incubated at 25°C for 4h (in a mixer or shaker) to obtain the GHK tripeptide after enzyme cleavage. The maximum yield of tripeptide-1 was calculated to be 220 mg / L.
[0050] (2) After the reaction is completed, the reaction solution is centrifuged at 4°C and 15,000 g for 20 min. Samples before and after the reaction are retained for SDS-PAGE to identify the enzyme cleavage effect.
[0051] (3) Use 3K and 1K ultrafiltration tubes to perform preliminary purification on the enzyme digestion supernatant to remove protein impurities with larger molecular weight.
[0052] (4) Collect the filtrate and freeze-dry it using a vacuum freeze dryer.
[0053] (5) The above samples were run on SDS-PAGE electrophoresis. The results were as follows Figure 2 As shown in the figure, alpha GHK28 aggregates can be directly digested by enzymes, but the supernatant contains a small amount of impurities. 2 O was used as the reaction system, and the supernatant after cleavage contained the least impurities.
[0054] Example 4: Preparation of blue copper peptide by chelating copper
[0055] (1) The freeze-dried sample was weighed and the chelation reaction was carried out according to the input ratio of tripeptide-1: copper chloride solution (0.3M) = 100 mg: 1 mL, and incubated at room temperature for 6 h (carried out in a mixer or shaker).
[0056] (2) The reaction solution was centrifuged at room temperature and 15000g for 20 min, and the supernatant was collected. Anhydrous ethanol was added at a volume ratio of supernatant to anhydrous ethanol = 1:7 to precipitate solids, and the solids were filtered or centrifuged (centrifuged at 25°C and 15000g for 5 min).
[0057] (3) The filter cake (or precipitate) is washed with distilled water and then dissolved in distilled water. The reaction solution is concentrated and freeze-dried to obtain the blue copper peptide GHK-Cu.
[0058] After weighing, it was estimated that the GHK-Cu shake flask fermentation yield reached 300 mg / L.
[0059] Example 5: HPLC Identification of Blue Copper Peptide
[0060] Detector: VWD UV detector;
[0061] Column: Agilent ZORBAX SB-C18 column (5 μM, 4.6*150 mm);
[0062] Injection volume 25 μL, flow rate 1 mL / min, column temperature 40 °C, detection wavelength 215 nm;
[0063] Mobile phase: aqueous solution containing 0.1% acetonitrile and 0.1% TFA (premixed), elution time 8 min.
[0064] The chelated blue copper peptide was subjected to HPLC identification, and the results were as follows: Figure 3 As shown, after the tripeptide-1 monomer chelates copper ions, the GHK-Cu product can be obtained with a purity of >98%.
[0065] Example 6: 5-L tank fermentation
[0066] In this example, the alpha GHK28 engineered bacteria monoclonal clone obtained in Example 1 was selected and placed in LB medium (containing kanamycin 50 μg / mL) and cultured at 37°C for 16-18 h. This was the primary seed solution, which was transferred to the fermentation medium at a 2% inoculation rate and cultured at 37°C until OD 600 At about 40°C, IPTG with a final concentration of 0.4 mM was added to induce expression for 12 hours, and then the fermentation was terminated. The cells were collected by centrifugation at 4°C and 4000 g. The subsequent operations were the same as those in Example 2-4.
[0067] OD at the end of the fermentation in the engineering tank 600 The yield of blue copper peptide is 150-200, of which the yield of blue copper peptide is 10-15g / L. Compared with other blue copper peptides, the yield is increased by dozens of times, which can meet the needs of industrialization.
Claims
1. A polypeptide alpha GHK28, characterized in that Its amino acid sequence is shown in SEQ ID No.
2.
2. A gene encoding the polypeptide alpha GHK28 according to claim 1.
3. The coding gene according to claim 2, characterized in that Its nucleotide sequence is shown in SEQ ID No.
1.
4. A plasmid expression vector, expressing the polypeptide alpha GHK28 according to claim 1.
5. The plasmid expression vector according to claim 4, characterized in that The plasmid expression vector is pET30a-alpha GHK28.
6. A host bacterium expressing the polypeptide alpha GHK28 according to claim 1.
7. The host bacteria according to claim 6, characterized in that The host bacteria is Escherichia coli.
8. A method for preparing tripeptide-1, characterized in that: The steps include: (1) constructing the plasmid expression vector according to claim 4 and transforming it into a host bacterium; (2) Cultivating the expression host bacteria and inducing the expression of the recombinant protein; (3) purifying the expression product to obtain the polypeptide alpha GHK28 according to claim 1; (4) The polypeptide alpha GHK28 was digested with trypsin and then separated and purified to obtain tripeptide-1.
9. A method for preparing Pro.GHK-Cu blue copper peptide with barrier repair and anti-aging effects, characterized in that: The steps include: (1) constructing the plasmid expression vector according to claim 4 and transforming it into a host bacterium; (2) Cultivating the expression host bacteria and inducing the expression of the recombinant protein; (3) purifying the expression product to obtain the polypeptide alpha GHK28 according to claim 1; (4) digesting the polypeptide alpha GHK28 with trypsin, separating and purifying to obtain tripeptide-1; (5) Tripeptide-1 chelates with copper ions to obtain blue copper peptide.
10. The preparation method according to claim 9, characterized in that: In step (5), cupric chloride solution is used as a chelating agent.
